EBS vs ECL
Emergent Biosolutions Inc (EBS) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
EBS currently screens at market cap $416.4M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the EBS and ECL stock pages for the full models.
Not investment advice.